Atlas Trials

Impact of an Optimized Communication on the Readmission for Adverse Drug Event

Clinical trial NCT03725046 · COMPLETED

Trial details

NCT number
NCT03725046
Sponsor
University Hospital, Montpellier
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Adverse Drug Event
Start date
2018-11-19
Primary completion
2021-07-19
Enrollment
346

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.